Abstract 2068P
Background
Sexual dysfunction is a frequently seen late effect in patients treated for testicular germ cell tumour (TGCT). Therefore, monitoring of sexual dysfunction is essential. The Utrecht Symptom Diary (USD) helps monitoring cancer symptoms, but items regarding sexuality are missing. Adding these symptoms may provide a better tailored tool, enhance monitoring of late effects on sexuality, and might help to address this topic. Therefore, the aim of this study was to explore perspectives and concerns on late effects regarding sexuality among adolescents and young adults (AYAs) being treated for TGCT to adapt the USD to make it suitable for follow-up care for these patients.
Methods
Individual, semi-structured interviews were conducted with thirteen AYAs from one centre of expertise for TGCT in the Netherlands. Patients were purposively sampled and using maximum variation. Data was analysed using Braun and Clark’s thematic analysis.
Results
Interviews revealed seven overarching themes which interact and overlap: fulfilment to have children, rediscover sexuality, insecurity about sexual performance, acceptance of physical change, loss of masculinity, burden on relationship, and need to talk about sexuality. Concerns related to the fulfilment to have children seems to play a major role.
Conclusions
Results help to better understand these men’s thoughts and experiences related to late effects regarding sexuality and gives healthcare professionals the opportunity to act on these topics by discussing it in the consulting room. Partner involvement seems beneficial.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2096P - Morphine titration with intravenous patient-controlled analgesia for severe cancer pain (Mr.TIPS)
Presenter: Seok Jae Huh
Session: Poster session 06
2097P - Incidence, risk factors (RFs) and management of oral mucositis (OM) in patients (pts) treated with a fluoropyrimidines (FP)-based therapy (tp): A retrospective, monocentric experience
Presenter: Fiorella Manfredi
Session: Poster session 06
2098P - The impact of concomitant use of non-opioid analgesics and immune checkpoint inhibitors on survival in lung cancer patients: A Hong Kong population-based cohort study
Presenter: Zheng-Hao Ye
Session: Poster session 06
2099P - The role of ambulatory blood pressure measurement in TKI-induced arterial hypertension diagnosis
Presenter: Elina Khachaturian
Session: Poster session 06
2100P - An exploratory study of the efficacy and safety of hetrombopag in the treatment of thrombocytopenia induced by concurrent or sequential chemoradiotherapy
Presenter: Jun Wang
Session: Poster session 06
2101P - Bleeding Induced by ANtiCAncer drugs (BIANCA) used breast cancer
Presenter: Nicolas Janus
Session: Poster session 06
2102P - Changes in opioid usage after intrathecal morphine pump implantation in patients with terminal cancer (pilot study)
Presenter: Eun Joo Choi
Session: Poster session 06
2103P - Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer
Presenter: Daniel Osei-Fofie
Session: Poster session 06
2104P - Prevention of taxane chemotherapy induced nail changes and peripheral neuropathy by application of extremity cooling: A prospective single center study with intrapatient comparison
Presenter: Kristen Johnson
Session: Poster session 06
2105P - Prophylactic role of a postbiotic microbiota-stabilizer on abemaciclib-induced diarrhea in breast cancer patients: A pilot application study
Presenter: Rita De Sanctis
Session: Poster session 06